YOLFTbeta
Jeil Pharm

Jeil Pharm

002620 · KO · Healthcare / Drug Manufacturers - Specialty & Generic

7,000.00KRW+130.00 (+1.89%)

Price History

Full chart

Market Stats

Previous Close6,870.00
Open6,870.00
Day Range6,870.00 – 7,130.00
52-Week Range6,050.00 – 9,850.00
Volume747
Market Cap113.75B
P/E (TTM)0.00
Forward P/E35.71
Dividend Yield0.92%
Beta0.46
50-Day Avg7,425.60
200-Day Avg7,902.05

About

Jeil Pharma Holdings Inc manufactures and sells ingredients of drugs, incrementally modified drugs, and generic drugs in South Korea. The company offers active pharmaceutical ingredients in the areas of antibiotics, gastrointestinal, cardiovascular, neuropsychiatry, oncology, endocrinology, urology, antiviral, and antihistamines, as well as patch products. It also provides finished dosage forms in the areas of anti-bacteria and anti-fungal, anti-virus, cardiovascular, endocrinology, neurology, gastrointestinal, urology, oncology, anti-histamine, rheumatology, respiratory, otolaryngological, heaptic, laxatives, and purgatives. The company exports its products to approximately 40 countries in the Association of Southeast Asian Nations, Central and South America, Africa, etc. The company was founded in 1959 and is headquartered in Seoul, South Korea.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Seung-Soo Han
  • Employees41
  • Headquarters343, Sapyeong-daero, Seoul, South Korea, 06543, Korea
  • Websitehttps://www.jeilpharm.co.kr

Leadership

  • Mr. Seung-Soo HanChairman of The Board and Chief Executive Officer · b. 1947

Financials

Income Statement

Currency: KRW2011-12-312012-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue462.85B426.82B594.72B617.28B44.44B142.74B725.46B762.00B762.57B792.96B804.04B779.82B657.61B
Growth (%)--7.79%+39.34%+3.79%-92.80%+221.18%+408.25%+5.04%+0.07%+3.99%+1.40%-3.01%-15.67%
Cost of Revenue329.68B319.04B454.75B482.15B23.13B86.28B549.16B570.76B582.06B612.48B589.46B573.30B404.12B
Gross Profit133.17B107.78B139.97B135.13B21.31B56.46B176.30B191.24B180.51B180.48B214.58B206.52B253.50B
Gross Margin28.77%25.25%23.53%21.89%47.95%39.55%24.30%25.10%23.67%22.76%26.69%26.48%38.55%
Operating Expense102.32B101.46B126.82B125.77B21.02B45.51B172.97B168.76B189.48B188.03B193.66B217.70B214.51B
Operating Income30.86B6.32B13.15B9.35B292.15M10.95B3.32B22.48B-8.97B-7.55B20.92B-11.18B38.99B
Operating Margin6.67%1.48%2.21%1.52%0.66%7.67%0.46%2.95%-1.18%-0.95%2.60%-1.43%5.93%
EBITDA----7.27B12.46B-71.96B42.67B6.14B-67.00B9.25B-38.65B61.81B
EBITDA Margin----16.36%8.73%-9.92%5.60%0.81%-8.45%1.15%-4.96%9.40%
Net Income27.01B11.17B9.76B7.89B518.82B7.07B-90.66B11.43B-3.48B-74.56B-16.25B-51.16B14.64B
Net Income Margin5.84%2.62%1.64%1.28%1167.44%4.95%-12.50%1.50%-0.46%-9.40%-2.02%-6.56%2.23%
R&D20.30B20.30B20.30B22.36B700.86M4.51B22.45B24.73B39.67B41.57B46.04B38.95B45.20B
R&D as % of Total Revenue4.39%4.76%3.41%3.62%1.58%3.16%3.09%3.25%5.20%5.24%5.73%4.99%6.87%
Interest Expense000001.02B2.86B3.19B3.29B5.95B10.67B8.87B7.49B
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.71%0.39%0.42%0.43%0.75%1.33%1.14%1.14%

Balance Sheet

Currency: KRW2011-12-312012-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets384.13B390.77B445.17B491.98B197.59B920.09B846.47B887.40B892.42B865.68B880.00B890.43B876.66B
Total Liabilities152.74B149.36B203.78B239.91B27.15B330.51B363.44B388.11B392.11B445.88B477.81B453.04B407.55B
Total Equity231.40B241.41B241.39B248.94B166.74B490.33B393.48B407.45B411.73B337.76B319.46B306.95B318.74B
Cash22.66B11.71B13.49B30.02B8.75B41.10B21.24B20.18B28.58B34.76B37.04B59.82B56.19B
Net Debt-----73.98B101.04B128.82B84.11B99.94B120.29B93.95B110.08B

Cash Flow

Currency: KRW2001-12-312002-12-312003-12-312011-12-312012-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow---23.63B-3.94B2.74B11.36B5.92B-3.43B25.22B-23.67B13.40B-20.80B-4.42B4.54B390.26M
Investing Cash Flow----24.75B-22.31B-4.00B-29.88B-3.79B-46.95B-40.85B-1.61B7.33B----
Financing Cash Flow----1.77B15.80B6.82B34.85B-23.80B77.68B-3.89B24.89B-12.24B----
Capital Expenditure00022.40B47.37B6.74B30.33B2.94B50.20B37.69B9.81B23.69B21.41B9.84B6.86B9.33B
Free Cash Flow-------2.95B-4.87B23.56B-33.94B-10.33B-42.21B-14.25B-2.32B-8.94B
Dividends Paid---1.31B1.17B772.81M764.19M891.21M223.32M1.52B1.59B1.59B1.47B1.13B1.13B183.17M
FCF to OCF-------49.84%141.88%93.42%143.37%-77.09%202.92%322.77%-51.10%-2290.23%
Dividend Paid to FCF-------30.19%-4.59%6.45%-4.67%-15.39%-3.49%-7.96%-48.85%-2.05%

Earnings

Report DateNov 14, 2004Feb 16, 2005Aug 11, 2005Jun 3, 2009Sep 2, 2009Dec 2, 2009Mar 3, 2010Jun 2, 2010Sep 1, 2010Dec 1, 2010Mar 2, 2011Jun 1, 2011Aug 31, 2011Nov 30, 2011Feb 29, 2012May 30, 2012Aug 29, 2012Nov 28, 2012Feb 27, 2013May 29, 2013Aug 28, 2013Nov 27, 2013Feb 26, 2014May 28, 2014Sep 3, 2014Dec 3, 2014Feb 25, 2015Jun 3, 2015Sep 2, 2015Dec 2, 2015Feb 11, 2016May 13, 2016Aug 12, 2016Nov 14, 2016Mar 9, 2017May 30, 2017Aug 29, 2017Nov 29, 2017Feb 23, 2018May 30, 2018Aug 29, 2018Nov 28, 2018Feb 27, 2019May 29, 2019Aug 28, 2019Nov 14, 2019May 13, 2020Aug 12, 2020Nov 12, 2020May 17, 2021Aug 13, 2021Nov 12, 2021May 13, 2022Aug 12, 2022Nov 11, 2022Feb 23, 2023May 12, 2023Aug 11, 2023Nov 13, 2023May 16, 2024Aug 14, 2024Nov 11, 2024Feb 24, 2025May 15, 2025Aug 12, 2025Nov 12, 2025Feb 23, 2026May 13, 2026Jun 30, 2026
EPS Estimate22.390.7616.06------------------------------------------------------------------
EPS Actual0.405.740.341697.022001.412130.841329.341501.671196.112034.951783.842616.171222.783076.374.751170.49923.711183.49-424.47647.75182.69188.28-881.67267.83895.56111.94-720.56299.93974.75418.49775.45518.81824.0639.47730.56221.48139101.29-27412.4327446.01382.59500.09459.09134.12106.35168.05142.02269.19198.62103.2356.67131.6965.62-480.8340.58-25.78-4726.92639.1181.97-16.95-1762.67-798.67-143.40-2393.44149.6495.10232.72475.9171.83-231.01
Surprise-98.21%655.26%-97.88%------------------------------------------------------------------
TimingAfter-hoursAfter-hoursPre-market---------------------------Pre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-market-------------Pre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-market-

Key Statistics & Ratios

Market Cap113.75B
Enterprise Value212.37B
Trailing P/E0.00
Forward P/E35.71
PEG Ratio0.00
Price / Sales0.18
Price / Book0.37
Revenue (TTM)630.89B
Gross Profit (TTM)256.69B
EBITDA33.95B
Profit Margin1.34%
Operating Margin-6.03%
Return on Equity5.55%
Return on Assets1.34%
Shares Outstanding15.35M
Shares Float2.16M
Beta0.46
Dividend Yield0.92%
Dividend Rate70.00
Payout Ratio12.74%

Dividends

20251×
70.00Dec 29, 2025
20241×
50.00Dec 27, 2024
20231×
50.00Dec 27, 2023
20221×
50.00Dec 28, 2022
20211×
65.00Dec 29, 2021
20201×
70.00Dec 29, 2020
20191×
70.00Dec 27, 2019
20181×
70.00Dec 27, 2018
20171×
60.00Dec 27, 2017
20161×
239.21Dec 28, 2016
20151×
205.04Dec 29, 2015
20141×
205.04Dec 29, 2014
20131×
136.69Dec 27, 2013
20121×
205.04Dec 27, 2012
20111×
307.56Dec 28, 2011
20101×
341.73Dec 29, 2010
20091×
341.73Dec 29, 2009
20081×
205.04Dec 29, 2008
20071×
358.82Dec 27, 2007
20061×
341.73Dec 27, 2006
20051×
392.99Dec 28, 2005
20041×
375.91Dec 29, 2004
20031×
341.73Dec 29, 2003
20021×
341.73Dec 27, 2002

Stock Splits

  • Jul 17, 20170.2926:1
  • Apr 19, 200610:1
  • Jan 4, 20001.0253:1